v3.25.2
EQUITY (Tables)
12 Months Ended
Jun. 30, 2025
Equity [Abstract]  
SCHEDULE OF WARRANTS OUTSTANDING

The remaining outstanding warrants as of June 30, 2025 are:

  

 

   Warrants Outstanding   Exercise Price   Expiration Date
            
July 2021 IPO   87,500   $7.00   June 2026
November 2021 SPA   481,000   $1.75   November 2026
November 2021 SPA   169,000   $1.75   May 2027
Total   737,500         
SCHEDULE OF STOCK OPTION FAIR VALUE ASSUMPTION

Stock options have been recorded at their fair value. The Black-Scholes option-pricing model assumptions used to value the issuance of stock options under the Plan for the specific periods below are noted in the following table:

    

   2025   2024 
   For the Years Ended
June 30,
 
   2025   2024 
Weighted average expected terms (in years)   5.5    5.1 
Weighted average expected volatility   125.6%   103.3%
Weighted average risk-free interest rate   4.3%   4.3%
Expected dividend yield   0.0%   0.0%
SUMMARY OF STOCK OPTION ACTIVITY

The following is a summary of the Company’s stock option activity for the years ended June 30, 2025 and 2024, excluding the executive Target Options:

   

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2024   3,643,880   $3.95    6.5   $- 
Options Granted   545,801    2.38    9.4    16,300 
Options Exercised   (35,600)   2.50    1.8    - 
Options Forfeited / Cancelled   (1,387,875)   4.53    6.8    9,942 
Outstanding at June 30, 2025   2,766,206   $3.37    5.6   $- 
Exercisable at June 30, 2025   1,850,129   $3.58    4.6   $- 
 
       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2023   6,128,381   $4.84    7.0   $1,676,966 
Options Granted   1,380,662    2.35    8.3    98,542 
Options Exercised   (25,000)   2.00    2.4    - 
Options Forfeited / Cancelled   (3,840,163)   4.81    6.5    - 
Outstanding at June 30, 2024   3,643,880   $3.95    6.5   $- 
Exercisable at June 30, 2024   1,973,499   $4.06    5.0   $- 
 
SCHEDULE OF STOCK OPTION BASED EXPENSE

The Company’s stock option-based expense for the years ended June 30, 2025 and 2024 consisted of the following:

   

   2025   2024 
   For the Years Ended 
   June 30 
   2025   2024 
Stock option-based expense :          
Research and development expenses  $210,498   $731,638 
General and administrative expenses   394,039    346,309 
Sales and marketing expenses   97,520    349,377 
Board option expense   229,389    179,950 
Total  $931,446   $1,607,274